Given that PD-L1 is aberrantly expressed on various cell types, including macrophage-lineage cells and tumor cells in cancer patients, the source of sPD-L1 in such individuals likely reflects this expression pattern (15). The gene discussed is SPDL1; the disease is neoplasm.